Radiotherapy in soft tissue sarcomas
|
|
- Suzanna Knight
- 6 years ago
- Views:
Transcription
1 Radiotherapy in soft tissue sarcomas Authors Key words L. Renard, X. Geets, P. Scalliet Soft tissue sarcoma, radiotherapy Summary Surgery and postoperative radiotherapy has become a standard of care in soft tissue sarcoma. A multidisciplinary approach by an expert team of physicians is required (surgical oncologist, radiation oncologist, medical oncologist, pathologist and imaging oncologist). Accurate pretreatment evaluation is critical for treating soft-tissue sarcomas. The indication for irradiation is based on pretreatment evaluation (size, location), type of surgery (marginal vs. wide excision margins) and tumor grade (low vs. high grade tumors). (BJMO 2008;vol 2;5:270-4) Introduction Sarcomas are rare malignant tumors that represent less than one percent of all cancers. They arise from skeletal and extra skeletal connective tissues. Roughly 78 percent of all sarcomas originate from soft tissue (soft tissue sarcoma, STS), the remainder arises from the bone. There are numerous histological subtypes of which undifferentiated pleomorph sarcoma and liposarcomas are most frequently observed. Because of the rarity of this pathology and the need for a multidisciplinary approach, these patients are best treated in centres having expertise in the management of sarcomas. 1,2 As large randomized trials are still awaited, the evidence for this has been built on small single-institution series and trials from experienced centres. 3 Surgery is the pivotal treatment for the majority of patients with localized soft tissue sarcoma. Considering the type of the surgery, amputation and compartmental resection offer the best local control. However, they have a high functional and cosmetic morbidity. If the surgical resection is marginal (R1), the recurrence rate is estimated between 60 and 90%. The recurrence rate is 100% in case of incomplete resection (R2). Wide excision offers the best compromise between local control and functional result when compartmental resection (quite large) and marginal resection (insufficient) are unfeasible. Thus, the goal of surgery is to remove the tumor with wide margins. This means removing at least one uninvolved tissue plane circumferentially. It is not as precisely defined as compartmental resection, but it specifies that margins must be clear with 2-5 cm of healthy tissue around the sarcoma (depending on grade and tumor size). Leaving a carefully considered positive margin adjacent to a critical structure to facilitate limb preservation, results in rates of local recurrence of only approximately 4% when planned irradiation is carried out. 4 The present review discusses indications of radiotherapy in localized STS. However, the topic of adjuvant or neoadjuvant medical treatment is not addressed. Figure 1 shows a decision tree for the treatment of STS. Radiotherapy alone Radiotherapy alone is considered when surgery is inappropriate or declined by the patient. It achieves local control rates of 30 to 60%. 5 However, it obviously depends on tumor characteristics. Some anecdotic series of patients, unfit for surgery (either for medical or for oncological reasons), have shown benefit from a protracted local control after high dose radiotherapy. The high dose level and the large volume of irradiation resulted in serious long-term effects in skin and soft tissues (fibrosis, necrosis). Overall the success rate was low, certainly not matching a multidisciplinary radio-surgical approach. Local control cannot be an objective when radiotherapy alone is used, except for tumors of limited size (perhaps < 5 cm). It may debulk the tumor and/or relieve compressive symptoms, or pain, but radiotherapy alone cannot be expected to control a large tumor mass. Concomitant radiochemotherapy has been discussed. Anthracyclines seem to have a supra-additive effect, but the cost in terms of skin toxicity is high
2 Y Tumour <5 Y Low grade Y Surgery Clear margins N N Follow-up every 6 months Consider Adjuvant irridiation Figure 1. Decision tree for the treatment of soft tissue sarcomas. (After Standards, Options et Recommandations 2006 pour la prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale. Revision 2005 ) The rationale for surgery plus radiotherapy As in the treatment of breast cancer, the goal of the conservative treatment in STS is to achieve a cure rate equivalent to amputation. This can be obtained by combining loco-regional radiotherapy with surgery. 4 The rationale for this combination is to avoid the functional and cosmetic deformities associated with radical surgery and the late sequel of high radiation doses to large volumes of normal tissue in patients treated with primary radiotherapy. Two small, single-institution randomized studies, reported by McNeere in 1968 and by Rosenberg in 1982 compared amputation to conservative surgery and adjuvant radiotherapy. 3,7 Both reported identical disease free survival and overall survival rates in the two arms. These trials have disqualified amputation as the primary treatment of STS. Two other randomized trials investigated the role of radiation in the setting of conservative surgery. In the trial reported by Pisters et al 164 patients with sarcoma of the extremities and the trunk were randomised preoperatively to receive adjuvant brachytherapy (45 Gy) or no further treatment after complete surgical resection. 8 The 5-year local control rates were 82% and 69% respectively for the whole population (p=0.04). For the high-grade tumors, the 5-year local control rate was significantly better in the arm with radiation (89% versus 66% p=0.0025). Nevertheless, the 5-year disease free survival was identical in both arms (84% and 81%), presumably because the improved local control in high-grade tumors was not associated with a reduction of distant metastasis. The second trial compared surgery alone to surgery plus postoperative external-beam radiotherapy, associated with chemotherapy for the high grade lesions. 9 The 10-year local control was extremely high with postoperative radiation: 100% for the highgrade tumors and 96% for the low grade. There were also no differences in the overall survival. Radio-chemotherapy has been investigated, mainly at UCLA. In a recent review it was concluded that this approach should still be considered investigational, since the late effects are clearly worse, without proven benefit. 10 Role of brachytherapy Brachytherapy is a form of radiotherapy that uses radioactive sources directly implanted in the tumor bed after local excision. It has the theoretical advantage over external radiotherapy of delivering a higher central dose, over a short period of time (one week typically). Because of the relative hypoxia in scar tissue it may be more efficient on tumor beds after surgery. 11 The practice of brachytherapy requires a specific training. The procedure is done during surgery for sarcoma, in coordination with the surgical oncologist. Non-radioactive catheters are deposited in the tumor bed and, in order to make sure that the physiological scarring process has started before irradiation, radioactive sources are inserted one week later. Accepted indications today small tumors (< 5cm) with insufficient clear margins (if re-excisions is not an option), recurring tumors of small size and recurring tumors that have already been irradiated at the time of surgery for the primary tumor. Formally, external beam radiotherapy and brachytherapy have never been compared in a randomized setting, but in the surgery plus radiotherapy arm of the Pisters trial brachytherapy was actually used. 9 Timing for the radiotherapy If radiation therapy improves local control, the sequencing between surgery and radiotherapy is still debated. A clinical trial from the Canadian Sarcoma Group sheds some light on this issue. 12 In this study, 190 patients diagnosed with soft-tissue sarcomas of the limbs were randomly assigned to preoperative radiotherapy (50 Gy in 25 fractions with a 16 Gy boost postoperative for microscopically positive surgical margins) followed by surgery vs. surgical 271
3 resection followed by postoperative radiotherapy (66 Gy). The primary endpoint was the presence or absence of major wound complications within 120 days after surgery. Secondary endpoints were local control, metastatic failure, progression-free survival and overall survival. The trial was closed before completion of the planned accrual. Thirty-one out of 88 eligible and evaluable patients (35%) developed wound complications in the preoperative arm versus 16 of 94 patients (17%) in the postoperative group (p=0.01). Delayed wound healing was observed specifically in sarcomas of the lower limbs. Although radiation oncologists clearly prefer preoperative irradiation (target volume easier to define, smaller irradiated volume, lower total dose), most surgeons fear the protracted wound healing process and prefer postoperative irradiation. 1 It remains a question open to debate, and long term data are needed to see if the late tolerance to treatment sufficiently improves (because of the lower dose) in order to justify the worse immediate tolerance of preoperative radiotherapy. In order to evaluate late morbidities (fibrosis, joint stiffness and oedema), O Sullivan updated the results of the Canadian Sarcoma Group at 2 years. 13 He concluded that patients treated with postoperative radiotherapy tended to have more fibrosis, which adversely affects patient s function. Tolerance to treatment Late effects are common, particularly in the skin, soft tissues and muscles. 14 Skin dystrophy (sclerosis, telangiectasia) is difficult to avoid around the surgical scar because this is one of the elective sites of recurrence that needs to receive full radiation dose. This can be corrected (at least partially) through the interpositioning of fresh, unirradiated, subcutaneous tissue. Occasionally the skin develops chronic radiolesions requiring skin grafts (especially in exposed areas as the tibial crest). Muscle sclerosis with functional loss is less common. As ankylosis may develop when joints are irradiated (if the sarcoma site requires it), protection of joints and ligaments should be taken into account during radiotherapy planning Lymphoedema is common after the treatment of large sarcomas of the lower limb. It is consecutive to sclerosis of skin and deep lymphatic vessels. It can be prevented, at least partially, by leaving a strip of healthy tissue, usually opposite to the irradiated compartment. Bone necrosis is less common (1 to 6%) and depends on the dose level and the irradiated volume. 15,16 Treatment of recurrences When recurrence is observed, amputation is required in 10 to 25% of the cases. Nevertheless, re-resection has to be considered. It will be followed by external radiotherapy if no radiation was delivered previously. When soft-tissue sarcomas recur in a previously irradiated area, further external beam radiation is generally impossible. In these cases brachytherapy allows a radiotherapeutic alternative in an attempt to reduce the risk of further local recurrence. 11 Isolated limb perfusion (mostly using melphalan) may also be an option. Addition of tumor necrosis factor α, a cytokine inducing inflammation, increases the penetration of melphalan into the tumor and may further improve the outcome. Retroperitoneal sarcomas Retroperitoneal sarcomas represent 13% of all sarcomas. Usually, the histological subtypes are liposarcoma and leiomyosarcoma. Sarcomas involving the retro-peritoneum have a worser outcome than soft tissue sarcomas located at the other side of the peritoneum. At diagnosis, retroperitoneal sarcomas are usually large and located in such a position that complete, margin-negative surgical resection, the most important prognostic factor for survival, is not feasible. In a series of 104 retroperitoneal sarcomas, treated by surgery and irradiation, a complete surgical excision rate of 43% was reported. 17 For this subgroup of patients, the survival rates at 5 and 10 years were 55% and 22% whereas the overall 5- and 10-years survival rates for the entire patient population were 36% and 14%. In contrast, those series reporting a high rate of surgical resectability, have better 5- and 10-year outcome (66% and 57% respectively), and lower local recurrence rates (25% at 5 years). 18 Histological grade is another important prognosis factor. Fifty percent of the retroperitoneal sarcomas are classified as intermediate or high grade. In a series of 183 patients treated for truncular or retroperitoneal sarcomas, high and intermediate grade patients had a five to six-fold increased risk of death. 19 The surrounding normal tissues (small bowel, spinal cord, kidney, liver) have a relatively low tolerance for radiation. Therefore, retroperitoneal sarcomas are not irradiated with the high radiation doses prescribed for soft tissue sarcoma of the extremities. Nevertheless, a non-randomized, retrospective study showed that adjuvant (postoperative) radiotherapy is associated with a reduced risk of local recurrence. However, this does not have a positive impact on survival. 272
4 Key messages for clinical practice 1. Postoperative radiotherapy is no substitute for inadequate surgery. 2. In case of unplanned, R1 or R2 resection, a surgical revision of the tumor bed needs to be discussed. 3. The superiority of preoperative radiotherapy to postoperative radiotherapy is still debated. 4. Preoperative radiotherapy increases the rate of delayed wound healing. 5. Postoperative radiotherapy seems to cause more late effects (fibrosis, loss of function). 6. Figure 1 on page 271 presents a decision tree for the treatment of soft tissue sarcomas. Preoperative radiotherapy offers practical advantages over postoperative radiation. First of all the gross tumor volume is easily defined allowing accurate targeting of the radiation dose. Secondly, the tumor displaces the organs at risk outside the high dose region. Pawlik et al reported the long-term results of two prospective trials of preoperative external radiotherapy for retroperitoneal sarcomas. 20 For 54 patients with primary retroperitoneal sarcoma who underwent R0 or R1 resection after preoperative radiotherapy, the 5-year local recurrence-free, diseasefree, and overall survival rates were 60%, 46% and 61% respectively. Practical considerations Accurate pretreatment evaluation is critical for treating soft-tissue sarcomas, particularly adequate imaging (MRI has preference). When an indication of radiotherapy is discussed, two elements should be taken into account: tumor grade (high grade tumors should be irradiated postoperatively, low grade tumors should not) and margin clearance. Margin clearance is a difficult aspect of STS. It depends on the surgeons skill, buttumor characteristics also have an important influence. The size determines whether limb sparing surgery is possible with clear margins. The location is also influencing margins: tumors close to bone periost or to neurovascular bundles, whatever their size, cannot be excised with broad margins unless vascular reconstruction or bone excision is used. A tumor of the lower limb in close contact to the fibula can still be excised together with the fibula itself. Hence, bone contact is not necessarily preventing clear margins. Retroperitoneal sarcomas, as discussed previously, are difficult to remove with a broad safety margin of healthy tissues. Oops surgery, i.e. the unplanned removal of a sarcoma, not previously diagnosed, is always inadequate and should be submitted to revision by an expert panel. Revision of the surgical field by an expert surgeon, postoperative irradiation, or wait-and-see policy must be debated. When the radiotherapy indication is confirmed, a careful study of the preoperative imaging and its further comparison with postoperative imaging is required, in order to adequately define the clinical target volume (CTV). A dose of 60 to 66 Gy in 30 to 33 daily fractions of 2 Gy is appropriate. 3-dimensional conformal techniques or IMRT should be used if it offers a dosimetric advantage (which is most oftenly the case). 21 Radiotherapy is not contraindicated after isolated limb perfusion with TNF, nor after skin flap for reconstruction Conclusion Postoperative radiotherapy is no substitute for inadequate surgery. In case of unplanned, R1 or a fortiori R2 resection, a surgical revision of the tumor bed always needs to be discussed. Whether preoperative radiotherapy is preferable above postoperative radiotherapy is still under debate. Preoperative radiotherapy doubles the rate of delayed wound healing (in lower limb tumors), but postoperative radiotherapy seems to cause more late effects (fibrosis, 273
5 loss of function). References 1. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994;65: Gutierrez JC, Perez EA, Moffat FL et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007;245: Pisters PW, O Sullivan B, Maki RG. Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 2007;25: Gerrand CH, Wunder JS, Kandel RA, et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 2001;83: Tepper JE, Suit HD. Radiation therapy alone for sarcoma of soft tissue. Cancer 1985;56: Lagarde P, Kantor G, Tawfiq N et al. Chemotherapy of soft tissue sarcoma in the adult. Cancer Radiother 1998;2: McNeer GP, Cantin J, Chu F, et al. Effectiveness of radiation therapy in the management of sarcoma of the soft somatic tissues. Cancer 1968;22: Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196: Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14: Pisters PW, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol 2002;9: Janjan N, Crane C, Delclos M, et al. Brachytherapy for locally recurrent soft-tissue sarcoma. Am J Clin Oncol 2002;25: O Sullivan B, Davis AM, Turcotte T, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359: Davis AM, O Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005;75: Pao WJ, Pilepich MV. Postoperative radiotherapy in the treatment of extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1990;19: Holt GE, Griffin AM, Pintilie M, et al. Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and lowdose radiotherapy. J Bone Joint Surg Am 2005;87: Keus RB, Rutgers EJ, Ho GH, et al. Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and longterm functional results. Eur J Cancer 1994;30A: Catton CN, O Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994;29: Karakousis CP, Velez AF, Gerstenbluth R, et al. Resectability and survival in retroperitoneal sarcomas. Ann Surg Oncol 1996;3: Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal softtissue sarcoma. Ann Surg 1995;221: Pawlik TM, Pisters PW, Mikula L et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006;13: O Sullivan B, Ward I, Catton C. Recent advances in radiotherapy for soft-tissue sarcoma. Curr Oncol Rep 2003;5: Olieman AF, Pras E, Van Ginkel RJ, et al. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 1998;40: Thijssens KM, Van Ginkel RJ, Pras E, et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann Surg Oncol 2006;13: Evans GR, Black JJ, Robb GL, et al. Adjuvant therapy: the effects on microvascular lower extremity reconstruction. Ann Plast Surg 1997;39: Correspondence address Authors: L. Renard, X. Geets, P. Scalliet Radiation oncology department, Cliniques Universitaires St Luc, Université de Louvain, Brussels, Belgium Please send all correspondence to: Dr. Laurette Renard Radiation Oncology department Cliniques Universitaires St Luc Université Catholique de Louvain avenue hippocrate Brussels Belgium laurette.renard uclouvain.be Conflicts of interest: The authors have nothing to disclose and indicate no potential conflicts of interest 274
Radiation Therapy for Soft Tissue Sarcomas
Radiation Therapy for Soft Tissue Sarcomas Alexander R. Gottschalk, MD, PhD Assistant Professor, Radiation Oncology University of California, San Francisco 1/25/08 NCI: limb salvage vs. amputation 43 patients
More informationRadiotherapy Considerations in Extremity Sarcoma
Radiotherapy Considerations in Extremity Sarcoma Peter Chung Department of Radiation Oncology Princess Margaret Hospital University of Toronto Role of RT in STS Local tumour eradication while allowing
More information14. Background. Sarcoma. Resectable extremity soft tissue sarcomas
96 14. Sarcoma Background Radiotherapy is widely used as an adjunct to surgery in the management of soft tissue sarcomas as the risk of failure in the surgical bed can be high. For bone sarcomas, radiotherapy
More informationWe considered whether a positive margin
Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence C. H. Gerrand, J. S. Wunder, R. A. Kandel, B. O Sullivan, C. N. Catton, R. S.
More information3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA
3D CONFORMATIONAL INTERSTITIAL BRACHYTHERAPY PLANNING FOR SOFT TISSUE SARCOMA Alina TĂNASE 1,3, M. DUMITRACHE 2,3, O. FLOREA 1 1 Emergency Central Military Hospital Dr. Carol Davila Bucharest, Romania,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated
More informationIntroduction ORIGINAL RESEARCH
Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey
More informationThe legally binding text is the original French version
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 2 April 2008 YONDELIS 0.25 mg, vial containing powder for concentrate for solution for infusion Box containing 1 vial
More informationMultidisciplinary management of retroperitoneal sarcomas
Multidisciplinary management of retroperitoneal sarcomas Eric K. Nakakura, MD UCSF Department of Surgery UCSF Comprehensive Cancer Center San Francisco, CA 7 th Annual Clinical Cancer Update North Lake
More informationAdvances in radiation oncology in the management of soft tissue sarcoma 放疗于治疗肉瘤的最新发展
Advances in radiation oncology in the management of soft tissue sarcoma 放疗于治疗肉瘤的最新发展 Brian O Sullivan Bartley-Smith / Wharton Chair Professor, Department of Radiation Oncology The Princess Margaret / University
More informationLimb Salvage Surgery for Musculoskeletal Oncology
Editorial Limb Salvage Surgery for Musculoskeletal Oncology Wan Faisham Nu man Bin Wan Ismail Submitted: 2 May 2015 Accepted: 18 June 2015 Orthopaedic Oncology Unit, Orthopaedic Department, School of Medical
More informationEffective local and systemic therapy is necessary for the cure of Ewing tumor Most chemotherapy regimens are a combination of cyclophosphamide,
Ewing Tumor Perez Ewing tumor is the second most common primary tumor of bone in childhood, and also occurs in soft tissues Ewing tumor is uncommon before 8 years of age and after 25 years of age In the
More informationINTRAOPERATIVE RADIATION THERAPY FOR RETROPERITONEAL SARCOMA
INTRAOPERATIVE RADIATION THERAPY FOR RETROPERITONEAL SARCOMA ISIORT 2014 Ivy A Petersen, MD Mayo Clinic Rochester, MN NOTHING TO DISCLOSE SOFT TISSUE SARCOMAS 2014 Estimated cases in the USA 12,020 diagnosed
More informationUpdate on Sarcomas of the Head and Neck. Kevin Harrington
Update on Sarcomas of the Head and Neck Kevin Harrington Overview Classification and incidence of sarcomas Clinical presentation Challenges to treatment Management approaches Prognostic factors Radiation-induced
More informationCorrelation of Radiologic and Pathologic Response in Patients Receiving Neoadjuvant Radiotherapy for Soft Tissue Sarcoma
ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.09.001765 Ramiz Abu-Hijlih MD. Biomed J Sci & Tech Res Research Article Open Access Correlation of Radiologic and Pathologic Response in
More informationRECURRENCE PATTERNS AND SURVIVAL FOR PATIENTS WITH INTERMEDIATE- AND HIGH-GRADE MYXOFIBROSARCOMA
doi:10.1016/j.ijrobp.2010.08.042 Int. J. Radiation Oncology Biol. Phys., Vol. 82, No. 1, pp. 361 367, 2012 Copyright Ó 2012 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/$ - see front
More informationExtraskeletal osteosarcoma of the hand: the role of marginal excision and adjuvant radiation therapy
HAND (2015) 10:602 606 DOI 10.1007/s11552-015-9760-0 REVIEW Extraskeletal osteosarcoma of the hand: the role of marginal excision and adjuvant radiation therapy Dana L. Casey 1 & Matt van de Rijn 2 & Geoffrey
More informationHypofractionated Radiotherapy for breast cancer: Updated evidence
2 rd Bangladesh Breast Cancer Conference, Dhaka, December 2017 Hypofractionated Radiotherapy for breast cancer: Updated evidence Tabassum Wadasadawala Associate Professor of Radiation Oncology Tata Memorial
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationPeri-Operative Brachytherapy In Soft-Tissue Sarcomas. Hospital USM Experience
ISPUB.COM The Internet Journal of Oncology Volume 7 Number 2 Peri-Operative Brachytherapy In Soft-Tissue Sarcomas. Hospital USM Experience B Biswal, N Idris, Z Wan, W Ismail, A Halim Citation B Biswal,
More informationWhat s New in Radiotherapy For STS of The Extremity? Kaled M. Alektiar, MD, FASTRO Dept of Rad Onc Memorial Sloan Kettering Cancer Center
What s New in Radiotherapy For STS of The Extremity? Kaled M. Alektiar, MD, FASTRO Dept of Rad Onc Memorial Sloan Kettering Cancer Center Topics Predictive tools for risk assessment Reassessment of dose/volume
More informationEnterprise Interest None
Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf
More informationConsensus Guideline on Accelerated Partial Breast Irradiation
Consensus Guideline on Accelerated Partial Breast Irradiation Purpose: To outline the use of accelerated partial breast irradiation (APBI) for the treatment of breast cancer. Associated ASBS Guidelines
More informationUPDATE ON RADIOTHERAPY
1 Miriam Kleiter UPDATE ON RADIOTHERAPY Department for Companion Animals and Horses, Plattform Radiooncology and Nuclear Medicine, University of Veterinary Medicine Vienna Introduction Radiotherapy has
More informationPrinted by Maria Chen on 3/11/2012 5:46:52 AM. For personal use only. Not approved for distribution. Copyright 2012 National Comprehensive Cancer
, Table of Contents NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level
More informationSoft Tissue Sarcoma. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee
Soft Tissue Sarcoma Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Soft Tissue Sarcoma Collective term for an unusual and diverse
More informationOral cavity cancer Post-operative treatment
Oral cavity cancer Post-operative treatment Dr. Christos CHRISTOPOULOS Radiation Oncologist Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Important issues RT -techniques Patient selection
More informationCorporate Medical Policy
Corporate Medical Policy Intensity-Modulated Radiation Therapy (IMRT) of the Prostate File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intensity_modulated_radiation_therapy_imrt_of_the_prostate
More informationEVIDENCE BASED MANAGEMENT FOR SOFT TISSUE SARCOMA
EVIDENCE BASED MANAGEMENT FOR SOFT TISSUE SARCOMA A Documentation of exact extent of primary tumor Clinical examination, X-ray, MRI (MRI has become the premier imaging modality for the evaluation of musculoskeletal
More informationHigh-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus. Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm.
High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm The Harvard community has made this article openly available. Please share
More informationSTAGING, BIOPSY AND NATURAL HISTORY OF TUMORS SCOTT D WEINER MD
STAGING, BIOPSY AND NATURAL HISTORY OF TUMORS SCOTT D WEINER MD WHAT DO YOU DO WHEN THIS SHOWS UP IN YOUR OFFICE? besides panicking KEY PRINCIPLE!!! Reactive zone is the edema, neovascularity and inflammation
More informationRadiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015
Radiation Treatment for Breast Cancer Melissa James Radiation Oncologist August 2015 OUTLINE External Beam Radiation treatment. (What is Radiation, doctor?) Role of radiation. (Why am I getting radiation,
More informationRadiotherapy Physics and Equipment
Radiological Sciences Department Radiotherapy Physics and Equipment RAD 481 Lecture s Title: Introduction Dr. Mohammed EMAM Ph.D., Paris-Sud 11 University Vision :IMC aspires to be a leader in applied
More informationCASE REPORT PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE.
PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE. M. Madan 1, K. Nischal 2, Sharan Basavaraj. C. J 3. HOW TO CITE THIS ARTICLE: M. Madan, K. Nischal,
More informationPartial Breast Irradiation using adaptive MRgRT
Partial Breast Irradiation using adaptive MRgRT Shyama Tetar, radiation-oncologist VUmc Amsterdam 15-12-2017 5 th Vumc SBRT symposium 2017 Current practice Breast conserving treatment (BCT) Breast conserving
More informationFactors influencing prognosis after initial inadequate excision (IIE) for soft tissue sarcoma
Sarcoma, September/December 2003, VOL. 7, NO. 3/4, 159 165 ORIGINAL ARTICLE Factors influencing prognosis after initial inadequate excision (IIE) for soft tissue sarcoma ALBERT N. VAN GEEL 1, ALEXANDER
More informationKoebner Phenomenon in Radiation Associated Angiosarcoma of the Breast: Linear Metastasis in Split Skin Graft Donor Site
ISPUB.COM The Internet Journal of Surgery Volume 9 Number 2 Koebner Phenomenon in Radiation Associated Angiosarcoma of the Breast: Linear Metastasis in Split Skin Graft Donor Site A Chhabra, A Goyal, R
More informationClinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate
Clinical Commissioning Policy Proposition: Proton Beam Therapy for Cancer of the Prostate Reference: NHS England B01X09 First published: March 2016 Prepared by NHS England Specialised Services Clinical
More informationRetroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients
Retroperitoneal Soft Tissue Sarcomas: Prognosis and Treatment of Primary and Recurrent Disease in 117 Patients INGO ALLDINGER 1,2, QIN YANG 3, CHRISTIAN PILARSKY 1, HANS-DETLEV SAEGER 1, WOLFRAM T. KNOEFEL
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationRADIOTHERAPY IN BREAST CANCER :
RADIOTHERAPY IN BREAST CANCER : PAST, PRESENT, FUTURE Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Cancer Institute Narayana Superspecialty Hospital Breast cancer is the classic paradigm
More informationRadiotherapy and tumours in veterinary practice: part one
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Radiotherapy and tumours in veterinary practice: part one Author : Aleksandra Marcinowska, Jane Dobson Categories : Companion
More informationis time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the
My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment
More informationSurgical strategies to improve results in retroperitoneal sarcoma. Christoph Kettelhack University Hospital Basel
Surgical strategies to improve results in retroperitoneal sarcoma Christoph Kettelhack University Hospital Basel Retroperitoneal Sarcoma General considerations Advanced tumor stage Complex anatomy Absence
More informationDiagnosis and management of retroperitoneal sarcoma
SON Update 2017 Diagnosis and management of retroperitoneal sarcoma Andrea J MacNeill, MD MSc FRCSC Surgical Oncologist, BC Cancer Agency Vancouver 2 Histologic Subtypes of STS 3 RP Subtypes (n=684) Extremity
More informationRUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES
RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES At the completion of Breast Fellowship training, the
More informationAge group No. of patients >60 15 Total 108
88 Original Article Soft Tissue Sarcoma in Uganda. A.M. Gakwaya 1, J. Jombwe 2, 1 Senior Consultant Surgeon, 2 Senior registrar, Dept. Of Surgery Mulago Hospital Complex, Kampala, Uganda Correspondence
More informationCURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER
CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER Jean-Pascal Machiels Department of medical oncology Institut I Roi Albert II Cliniques universitaires Saint-Luc Université catholique de Louvain, Brussels,
More informationPreoperative adjuvant radiotherapy
Preoperative adjuvant radiotherapy Dr John Hay Radiation Oncology Program BC Cancer Agency Vancouver Cancer Centre The key question for the surgeon Do you think that this tumour can be resected with clear
More informationAdvances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015
Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy
More informationCarcinoma del retto: Highlights
Carcinoma del retto: Highlights Stefano Cordio Struttura Complessa di Oncologia Medica ARNAS Garibaldi Catania Roma 17 Febbraio 2018 Disclosures Advisory Committee, research funding and speakers bureau
More informationProtocol of Radiotherapy for Breast Cancer
107 年 12 月修訂 Protocol of Radiotherapy for Breast Cancer Indication of radiotherapy Indications for Post-Mastectomy Radiotherapy (1) Axillary lymph node 4 positive (2) Axillary lymph node 1-3 positive:
More informationThank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS.
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM MENINGIOMA CNS Site Group Meningioma Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION 3 2. PREVENTION
More informationUniversity of Groningen
University of Groningen Isolated limb perfusion and external beam radiotherapy for soft tissue sarcomas of the extremity Hoven-Gondrie, M.L.; Thijssens, K.M.; Geertzen, Jan H.B; Pras, E.; van Ginkel, Robert;
More informationSoft-tissue sarcoma of the thigh
72 Acta Orthop Scand 2001; 72 (1): 72 77 Soft-tissue sarcoma of the thigh Surgical margin influences local recurrence but not survival in 152 patients Søren Vraa, Johnny Keller, Ole Steen Nielsen, Anne
More informationAdvances in Localized Breast Cancer
Advances in Localized Breast Cancer Melissa Camp, MD, MPH and Fariba Asrari, MD June 18, 2018 Moderated by Elissa Bantug 1 Advances in Surgery for Breast Cancer Melissa Camp, MD June 18, 2018 2 Historical
More informationHypofractionated radiation therapy for glioblastoma
Hypofractionated radiation therapy for glioblastoma Luis Souhami, MD, FASTRO Professor McGill University Department of Oncology, Division of Radiation Oncology Montreal Canada McGill University Health
More informationNIPPLE SPARING PRE-PECTORAL BREAST RECONSTRUCTION
NIPPLE SPARING PRE-PECTORAL BREAST RECONSTRUCTION 42 yo female healthy athlete Right breast mass. Past medical history: none Family history: aunt with Breast cancer Candidates for nipple-sparing mastectomy
More informationModalities of Radiation
Modalities of Radiation Superficial radiotherapy Orthovoltage Megavoltage Photons Electrons Brachytherapy Interstitial Moulds When to refer? The vast majority of skin cancers will be managed without any
More informationClinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience
Original Article Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience Rachel Murray 1, Fantine Giap 2, Ray Lin
More informationSarcoma and Radiation Therapy. Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington
Sarcoma and Radiation Therapy Gabrielle M Kane MB BCh EdD FRCPC Muir Professorship in Radiation Oncology University of Washington Objective: Helping you make informed decisions Introduction Process Radiation
More informationAdjuvant radiation therapy of retroperitoneal sarcoma: the role of intraoperative radiotherapy (IORT)
Sarcoma (2000) 4, 11± 16 ORIGINAL ARTICLE Adjuvant radiation therapy of retroperitoneal sarcoma: the role of intraoperative radiotherapy (IORT) KENNETH S. HU 1 & LOUIS B. HARRISON 1,2 1 The Charles and
More informationRecurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas
ORIGINAL ARTICLE The ANNALS of AFRICAN SURGERY www.sskenya.org Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas Motanya JB 1, Saidi H 2 1 Molo District Hospital, Nakuru, Kenya
More informationMalcolm Mattes, MD Ajay Tejwani, MD, MPH New York Methodist Hospital
Malcolm Mattes, MD Ajay Tejwani, MD, MPH New York Methodist Hospital 39 year old female patient who felt a mass in the right gluteal area. Slowly growing over the course of 2 3 months. The mass is associated
More informationNEOADJUVANT THERAPY IN CARCINOMA STOMACH. Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Superspeciality Hospital, Howrah
NEOADJUVANT THERAPY IN CARCINOMA STOMACH Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Superspeciality Hospital, Howrah NEOADJUVANT THERAPY?! Few believers Limited evidence Many surgeons
More informationEarly Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh
Early Rectal Cancer Surgical options Organ Preservation? Chinna Reddy Colorectal Surgeon Western General, Edinburgh What is Early rectal cancer? pt1t2n0m0 Predictors for LN involvement Size Depth Intramural
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationUCL. Rectum Adenocarcinoma. Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans
Rectum Adenocarcinoma Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans Fifth Belgian Surgical Week May 6th, 2004, Oostende SOR rectum adenocarcinoma Indication of radiotherapy
More informationCombined chemotherapy and Radiotherapy for Patients with Breast Cancer and Extensive Nodal Involvement.
Combined chemotherapy and Radiotherapy for Patients with Breast Cancer and Extensive Nodal Involvement. Ung O, Langlands A, Barraclough B, Boyages J. J Clin Oncology 13(2) : 435-443, Feb 1995 STUDY DESIGN
More informationBone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery
Bone HDR brachytherapy in a patient with recurrent Ewing s sarcoma of the acetabulum: Alternative to aggressive surgery Rafael Martínez-Monge 1,* Agata Pérez-Ochoa 1, Mikel San Julián 2, Dámaso Aquerreta
More informationDecision making in surgical oncology- when to cut big, when to cut small
Decision making in surgical oncology- when to cut big, when to cut small Simon T. Kudnig, BVSc, MVS, MS, FANZCVSc, Dipl. ACVS ACVS Founding Fellow in Surgical Oncology Animal Referral Hospital, Melbourne,
More informationReconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb
Journal of Orthopaedic Surgery 2005;13(1):58-63 Reconstructive treatment following resection of high-grade soft-tissue sarcomas of the lower limb AM Leow, AS Halim Reconstructive Sciences Department, Hospital
More informationXXII Congresso Nazionale AIRO
XXII Congresso Nazionale AIRO Roma, 17-20 Novembre 2012. I Sarcomi delle Parti Molli dell adulto: Terapia Adiuvante vs Terapia Neoadiuvante Antonino De Paoli UO Oncologia Radioterapica Centro di Riferimento
More informationJMSCR Volume 03 Issue 05 Page May 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Clinical Study of Soft Tissue Sarcoma Cases in A South-Indian Teaching Hospital Authors Dr.D.Abhivardhan 1, Dr Ch.V.Sivakumar 2, Dr Lakshmi
More informationSubject Index. Androgen antiandrogen therapy, see Hormone ablation therapy, prostate cancer synthesis and metabolism 49
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Androgen antiandrogen therapy, see Hormone ablation therapy, synthesis and metabolism 49 Bacillus Calmette-Guérin adjunct therapy with transurethral resection
More informationPan Arab Journal of Oncology
Pan Arab Journal of Oncology Original Article Retrospective Analysis of Clinicopathologic and Management Aspects of Soft Tissue Sarcoma Tarek Hussein Kamel, Azza Mohamed Adel, Reham Mohamed Faheim, Rana
More informationNeoadjuvant radiotherapy for pancreatic cancer: rationale and outcomes
Review Article Neoadjuvant radiotherapy for pancreatic cancer: rationale and outcomes Rohan Deraniyagala, Emily D. Tanzler The University of Florida College of Medicine Department of Radiation Oncology,
More informationINTRAOPERATIVE ELECTRON-BEAM THERAPY FOR PRIMARY AND RECURRENT RETROPERITONEAL SOFT-TISSUE SARCOMA
doi:10.1016/j.ijrobp.2006.01.028 Int. J. Radiation Oncology Biol. Phys., Vol. 65, No. 3, pp. 773 779, 2006 Copyright 2006 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/06/$ see front
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationBreast Surgery: Yesterday, Today and Tomorrow
Breast Surgery: Yesterday, Today and Tomorrow Baptist Hospital Gladys L. Giron, MD, FACS October 11,2014 Homestead Hospital Baptist Children s Hospital Doctors Hospital Baptist Cardiac & Vascular Institute
More informationBLADDER RADIOTHERAPY PLANNING DOCUMENT
A 2X2 FACTORIAL RANDOMISED PHASE III STUDY COMPARING STANDARD VERSUS REDUCED VOLUME RADIOTHERAPY WITH AND WITHOUT SYNCHRONOUS CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER (ISRCTN 68324339) BLADDER RADIOTHERAPY
More informationIAEA Pediatric Radiation Oncology Training Dr Laskar Version 1 June SOFT TISSUE SARCOMA (Non Rhabdomyosarcoma)
SOFT TISSUE SARCOMA (Non Rhabdomyosarcoma) Soft Tissue structures Fat, Muscles, Fibrous tissue, Blood vessels, Supporting cells of peripheral nervous system Soft Tissue Sarcomas:- embryologically arise
More informationRecurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction
Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing
More informationAmerican Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy
Brachytherapy 12 (2013) 179e190 American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy Caroline L. Holloway 1, *, Thomas F. DeLaney 2, Kaled M. Alektiar 3, Phillip M. Devlin
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationAMORE (Ablative surgery, MOulage technique brachytherapy and REconstruction) for childhood head and neck rhabdomyosarcoma Buwalda, J.
UvA-DARE (Digital Academic Repository) AMORE (Ablative surgery, MOulage technique brachytherapy and REconstruction) for childhood head and neck rhabdomyosarcoma Buwalda, J. Link to publication Citation
More informationSacral Chordoma: The Loma Linda University Radiation Medicine Experience. Kevin Yiee MD, MPH Resident Physician
Sacral Chordoma: The Loma Linda University Radiation Medicine Experience Kevin Yiee MD, MPH Resident Physician What is a chordoma? 1 st chordoma discovered in clivus by Virchow and Luschka 1856 Rare tumor
More informationDa Costa was the first to coin the term. Marjolin s Ulcer: A Case Report and Literature Review. Case Report. Introduction
E-Da Medical Journal 2016;3(2):24-28 Case Report Marjolin s Ulcer: A Case Report and Literature Review Yue-Chiu Su 1, Li-Ren Chang 2 Marjolin s ulcer is an aggressive cutaneous malignancy, which is common
More informationShould soft tissue sarcomas be treated at a specialist centre?
Sarcoma, March 2004, VOL. 8, NO. 1, 1 6 ORIGINAL ARTICLE Should soft tissue sarcomas be treated at a specialist centre? A.A. BHANGU 1, J.A.S BEARD 1 & R.J. GRIMER 2 1 University of Birmingham Medical School,
More informationRetroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors
Original Article Radiat Oncol J 216;34(3):216222 http://dx.doi.org/1.3857/roj.216.1858 pissn 223419 eissn 22343156 Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic
More informationBreast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
More informationPosition Statement on Management of the Axilla in Patients with Invasive Breast Cancer
- Official Statement - Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) for the
More informationWhat s new in bone and soft tissue sarcoma Treatment and Guidelines 2012? Rob Grimer
What s new in bone and soft tissue sarcoma Treatment and Guidelines 2012? Rob Grimer ESMO conference 2012 Top Oncologists in world (~ 400) Lots of sarcoma basic science key messages: 40% of STS diagnoses
More informationOutcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study
Original Article Outcome of rectal cancer after radiotherapy with a long or short waiting period before surgery, a descriptive clinical study Elmer E. van Eeghen 1, Frank den Boer 2, Sandra D. Bakker 1,
More informationCPT Codes: 77424, Last Review Date: July 2017 Guideline Number: NIA_CG_226 Last Revised Date: July 2017 Responsible Department:
Magellan Healthcare Clinical guideline: INTRAOPERATIVE RADIATION THERAPY (IORT) Original Date: November 2013 Page 1 of 5 CPT Codes: 77424, 77425 Last Review Date: July 2017 Guideline Number: NIA_CG_226
More informationEfficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma
Original Article Yonsei Med J 2018 Nov;59(9):1049-1056 pissn: 0513-5796 eissn: 1976-2437 Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma
More informationPrognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
Rare Tumors 2013; volume 5:e55 Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients Ling Cai, 1 René-Olivier
More informationResearch Article Liposarcoma of the Spermatic Cord: Impact of Final Surgical Intervention An Institutional Experience
Hindawi Publishing Corporation International Journal of Surgical Oncology Volume 2016, Article ID 4785394, 5 pages http://dx.doi.org/10.1155/2016/4785394 Research Article Liposarcoma of the Spermatic Cord:
More informationTherapeutic ratio - An Overview. Past Present Future Prof Ramesh S Bilimaga
Therapeutic ratio - An Overview Past Present Future Prof Ramesh S Bilimaga Radiation Oncology Discipline of human medicine concerned with the generation, conservation and dissemination of knowledge concerning
More information